BeyondSpring Inc. (BYSI) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
10/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseBYSI / S&P 6.71% / 15.20% |
LoseBYSI / S&P BYSI unavailable / 15.00% |
LoseBYSI / S&P BYSI unavailable / 50.40% |
| 2026-Q11/3 |
WinBYSI / S&P 0.61% / -4.33% |
LoseBYSI / S&P BYSI unavailable / 11.30% |
LoseBYSI / S&P BYSI unavailable / 27.70% |
| 2025-Q40/3 |
LoseBYSI / S&P -9.94% / 2.65% |
LoseBYSI / S&P BYSI unavailable / 9.00% |
LoseBYSI / S&P BYSI unavailable / 13.40% |
| 2025-Q30/3 |
LoseBYSI / S&P -22.98% / 8.12% |
LoseBYSI / S&P BYSI unavailable / 4.61% |
LoseBYSI / S&P BYSI unavailable / 13.45% |
| 2025-Q21/3 |
WinBYSI / S&P 63.76% / 10.94% |
LoseBYSI / S&P BYSI unavailable / 4.83% |
LoseBYSI / S&P BYSI unavailable / 10.63% |
| 2025-Q10/3 |
LoseBYSI / S&P -11.96% / -4.27% |
LoseBYSI / S&P BYSI unavailable / 4.98% |
LoseBYSI / S&P BYSI unavailable / 10.57% |
| 2024-Q40/3 |
LoseBYSI / S&P -28.82% / 2.41% |
LoseBYSI / S&P BYSI unavailable / 5.25% |
LoseBYSI / S&P BYSI unavailable / 6.15% |
| 2024-Q30/3 |
LoseBYSI / S&P -4.58% / 5.89% |
LoseBYSI / S&P BYSI unavailable / 5.89% |
LoseBYSI / S&P BYSI unavailable / 6.11% |
| 2024-Q20/3 |
LoseBYSI / S&P -32.77% / 4.28% |
LoseBYSI / S&P BYSI unavailable / 5.38% |
LoseBYSI / S&P BYSI unavailable / 5.12% |
| 2024-Q11/3 |
WinBYSI / S&P 296.67% / 10.56% |
LoseBYSI / S&P BYSI unavailable / 5.71% |
LoseBYSI / S&P BYSI unavailable / 5.59% |
| 2023-Q41/3 |
WinBYSI / S&P 12.50% / 11.69% |
LoseBYSI / S&P BYSI unavailable / 6.81% |
LoseBYSI / S&P BYSI unavailable / 7.78% |
| 2023-Q30/3 |
LoseBYSI / S&P -32.20% / -3.27% |
LoseBYSI / S&P BYSI unavailable / 7.52% |
LoseBYSI / S&P BYSI unavailable / -5.03% |
| 2023-Q20/3 |
LoseBYSI / S&P 5.36% / 8.74% |
LoseBYSI / S&P BYSI unavailable / 9.50% |
LoseBYSI / S&P BYSI unavailable / -8.57% |
| 2023-Q10/3 |
LoseBYSI / S&P -40.43% / 7.50% |
LoseBYSI / S&P BYSI unavailable / 10.77% |
LoseBYSI / S&P BYSI unavailable / -15.69% |
| 2022-Q41/3 |
WinBYSI / S&P 89.90% / 7.56% |
LoseBYSI / S&P BYSI unavailable / 11.88% |
LoseBYSI / S&P BYSI unavailable / -17.99% |
| 2022-Q30/3 |
LoseBYSI / S&P -31.25% / -4.88% |
LoseBYSI / S&P BYSI unavailable / 13.47% |
LoseBYSI / S&P BYSI unavailable / -1.41% |
| 2022-Q20/3 |
LoseBYSI / S&P -34.55% / -16.10% |
LoseBYSI / S&P BYSI unavailable / 13.71% |
LoseBYSI / S&P BYSI unavailable / 11.04% |
| 2022-Q10/3 |
LoseBYSI / S&P -51.43% / -4.60% |
LoseBYSI / S&P BYSI unavailable / 15.97% |
LoseBYSI / S&P BYSI unavailable / 42.23% |
| 2021-Q40/3 |
LoseBYSI / S&P -71.26% / 11.03% |
LoseBYSI / S&P BYSI unavailable / 15.00% |
LoseBYSI / S&P BYSI unavailable / 96.40% |
| 2021-Q31/3 |
WinBYSI / S&P 50.96% / 0.58% |
LoseBYSI / S&P BYSI unavailable / 10.77% |
LoseBYSI / S&P BYSI unavailable / 69.42% |
| 2021-Q20/3 |
LoseBYSI / S&P -5.69% / 8.55% |
LoseBYSI / S&P BYSI unavailable / 6.58% |
LoseBYSI / S&P BYSI unavailable / 51.81% |
| 2021-Q10/3 |
LoseBYSI / S&P -9.26% / 6.17% |
LoseBYSI / S&P BYSI unavailable / -1.06% |
LoseBYSI / S&P BYSI unavailable / 7.39% |
| 2020-Q40/3 |
LoseBYSI / S&P -8.34% / 12.15% |
LoseBYSI / S&P BYSI unavailable / -3.72% |
LoseBYSI / S&P BYSI unavailable / -33.42% |
| 2020-Q30/3 |
LoseBYSI / S&P -11.74% / 8.93% |
LoseBYSI / S&P BYSI unavailable / -2.04% |
LoseBYSI / S&P BYSI unavailable / -27.10% |
| 2020-Q20/3 |
LoseBYSI / S&P 17.72% / 20.54% |
LoseBYSI / S&P BYSI unavailable / -0.46% |
LoseBYSI / S&P BYSI unavailable / -27.11% |
| 2020-Q11/3 |
WinBYSI / S&P -17.35% / -19.60% |
LoseBYSI / S&P BYSI unavailable / 3.47% |
LoseBYSI / S&P BYSI unavailable / -14.75% |
| 2019-Q40/3 |
LoseBYSI / S&P -14.36% / 9.07% |
LoseBYSI / S&P BYSI unavailable / 5.36% |
LoseBYSI / S&P BYSI unavailable / 2.99% |
| 2019-Q30/3 |
LoseBYSI / S&P -23.63% / 1.70% |
LoseBYSI / S&P BYSI unavailable / 5.02% |
LoseBYSI / S&P BYSI unavailable / 0.21% |
| 2019-Q21/3 |
WinBYSI / S&P 47.99% / 4.30% |
LoseBYSI / S&P BYSI unavailable / 6.64% |
LoseBYSI / S&P BYSI unavailable / 8.65% |
| 2019-Q10/3 |
LoseBYSI / S&P -14.59% / 13.65% |
LoseBYSI / S&P BYSI unavailable / 8.12% |
LoseBYSI / S&P BYSI unavailable / 14.29% |
| 2018-Q40/3 |
LoseBYSI / S&P -25.03% / -13.52% |
LoseBYSI / S&P BYSI unavailable / 9.05% |
LoseBYSI / S&P BYSI unavailable / 18.23% |
| 2018-Q30/3 |
LoseBYSI / S&P -5.66% / 7.71% |
LoseBYSI / S&P BYSI unavailable / 10.21% |
LoseBYSI / S&P BYSI unavailable / 19.06% |
| 2018-Q21/3 |
WinBYSI / S&P 3.47% / 3.43% |
LoseBYSI / S&P BYSI unavailable / 9.03% |
LoseBYSI / S&P BYSI unavailable / 14.46% |
| 2018-Q10/3 |
LoseBYSI / S&P -11.90% / -0.76% |
LoseBYSI / S&P BYSI unavailable / 7.68% |
LoseBYSI / S&P BYSI unavailable / 12.46% |
| 2017-Q40/3 |
LoseBYSI / S&P -21.13% / 6.64% |
LoseBYSI / S&P BYSI unavailable / 7.03% |
LoseBYSI / S&P BYSI unavailable / 13.82% |
| 2017-Q30/3 |
LoseBYSI / S&P -14.01% / 4.48% |
LoseBYSI / S&P BYSI unavailable / 5.68% |
LoseBYSI / S&P BYSI unavailable / 17.57% |
| 2017-Q21/3 |
WinBYSI / S&P 115.13% / 3.09% |
LoseBYSI / S&P BYSI unavailable / 4.83% |
LoseBYSI / S&P BYSI unavailable / 17.74% |
| 2017-Q10/3 |
LoseBYSI / S&P BYSI unavailable / 6.07% |
LoseBYSI / S&P BYSI unavailable / 3.67% |
LoseBYSI / S&P BYSI unavailable / 13.32% |
| 2016-Q40/3 |
LoseBYSI / S&P BYSI unavailable / 3.82% |
LoseBYSI / S&P BYSI unavailable / 2.09% |
LoseBYSI / S&P BYSI unavailable / 7.05% |
| 2016-Q30/3 |
LoseBYSI / S&P BYSI unavailable / 3.85% |
LoseBYSI / S&P BYSI unavailable / 0.20% |
LoseBYSI / S&P BYSI unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | BYSI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -62.79% | 20.78% |
| Annualized return | -62.79% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | BYSI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.75% | 83.14% |
| Annualized return | -53.19% | 12.86% |
10Y · 2017-03-09 to 2026-08-27
| Metric | BYSI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -96.19% | 319.30% |
| Annualized return | -27.87% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |